Cefotan

Active Ingredient(s): Cefotetan
FDA Approved: * December 27, 1985
Pharm Company: * ASTRAZENECA
Category: Antibiotics

Cefotetan is an injectable antibiotic of the cephamycin type for prophylaxis and treatment of bacterial infections. It is often grouped together with second-generation cephalosporins and has a similar antibacterial spectrum, but with additional anti-anaerobe coverage. Cefotetan was developed by Yamanouchi. It is marketed outside Japan by AstraZeneca with the brand names Apatef and Cefotan. Contents 1 Adverse effects 2 Spectrum of bacterial susceptibility 3 References 4 External links A... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cefotan 1 g/10ml Intramuscular; Intravenous Injection, Powder, for Solution

NDC: 0121-0976

Labeler:

Pai Holdings, LLC Dba Pai Pharma

Cefotan 2 g/20ml Intramuscular; Intravenous Injection, Powder, for Solution

NDC: 0121-0977

Labeler:

Pai Holdings, LLC Dba Pai Pharma

Cefotan 1 g/10ml Intramuscular; Intravenous Injection, Powder, for Solution

NDC: 52565-052

Labeler:

Teligent Pharma, Inc.

Cefotan 2 g/20ml Intramuscular; Intravenous Injection, Powder, for Solution

NDC: 52565-053

Labeler:

Teligent Pharma, Inc.